On Thursday, Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD), lost -1.49% to $1.98, hitting its lowest level.
Advanced Micro Devices, declared the new AMD FirePro™ S9170 server GPU, the world’s first and fastest 32GB single-GPU server card for DGEMM heavy double-precision workloads, with support for OpenCL™ 2.0. Based on the second-generation AMD Graphics Core Next (GCN) GPU architecture, this new addition to the AMD FirePro™ server GPU family is capable of delivering up to 5.24 TFLOPS of peak single precision compute performance while enabling full throughput double precision performance, providing up to 2.62 TFLOPS of peak double precision performance.
- Designed with compute-intensive workflows in mind, the AMD FirePro S9170 server GPU is ideal for data center managers who oversee clusters within academic or government bodies, oil and gas industries, or deep neural network compute cluster development.
- The AMD FirePro S9170 offers unparalleled GPU compute performance and power efficiency with the following benefits:
- With up to 2.62 TFLOPS of peak double precision performance, the AMD FirePro S9170 is the fastest single-GPU server card accessible for DGEMM heavy workloads, delivering up to 40% more performance than the competitive solution;
- Support for 40% better double precision performance, while using 10% less power than the competition;
- The AMD FirePro S9170 is the industry’s first server GPU with 32GB ultra-fast GDDR5 on-board memory and features a 512-bit memory interface for 320 GB/s of memory bandwidth;
- Equipped with 32GB of GDDR5 memory, the AMD FirePro S9170 GPU can accelerate memory-intensive applications and process larger and more computationally complex workloads with ease; and
- The AMD FirePro S9170 GPU features 33% more memory than the competitive GPU, assisting to improve overall workload speed and system responsiveness, especially when working with large amounts of data.
AMD (NASDAQ: AMD) designs and integrates technology that powers millions of intelligent devices, counting personal computers, tablets, game consoles and cloud servers that define the new era of surround computing.
Shares of Goldcorp Inc. (NYSE:GG), declined -0.24% to $16.67, during its last trading session.
Goldcorp, declared that it has extended the deadline for former shareholders of Probe Mines (“Probe”) to file tax election forms to August 31, 2015.
The exchange of Probe shares for Goldcorp shares and cash is considered a taxable event for Canadian income tax purposes. However, it is possible to defer some or all of any tax resulting from the share exchange by filing a Section 85 Tax Election Form, and submitting the Tax Election Form to the Canada Revenue Agency. A manual Section 85 Tax Election form must be filed with the Canada Revenue Agency and, where applicable, with the provinces of Quebec and Alberta. Goldcorp has engaged PricewaterhouseCoopers LLP (Canada) to provide access to a website tool to prepare and print your Section 85 Tax Election form and any applicable similar joint election under provincial legislation. Once the election(s) is printed from the PwC website, you must sign and file the signed election forms with the applicable Canadian federal and provincial tax authorities as outlined in the Probe Mines Administration Information Circular.
It is the sole responsibility of each Probe Mines Shareholder to correctly complete and print a Section 85 Tax Election by 31 August 2015. After August 2015, the website may be closed preventing any further processing and printing of Section 85 Tax Election forms after that date.
Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America.
Finally, Amicus Therapeutics, Inc. (NASDAQ:FOLD), ended its last trade with 1.96% gain, and closed at $14.04.
Amicus Therapeutics, has been added to the U.S. broad-market Russell 3000(R) and small-cap Russell 2000(R) Indexes. The Company joined the indexes at the close of market on Friday, June 26, 2015, when Russell Investments reconstituted its U.S. and global equity indexes.
Annual reconstitution of Russell’s U.S. indexes captures and ranks the 4,000 largest U.S. stocks as of the end of May by total market capitalization. The Russell 3000 Index measures the performance of the largest 3,000 U.S. companies representing about 98% of the investable U.S. equity market. Membership in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000(R) Index or small-cap Russell 2000 Index in addition to the appropriate growth and value style indexes. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.
John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics, Inc., stated, “We are happy to join the Russell 3000 and 2000, which are used by multiple investment managers and institutional investors for index funds in addition to benchmarks for active investment strategies. Amicus is now among the largest U.S. public companies, and our inclusion in these indexes further broadens our exposure to a vast new set of portfolios.”
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
